Answers are grounded in this paper and cite their sources.
Figure S4 shows loss of BCL-XL and BYL719 treatment in additional gastric cancer cell line
No takes yet. Share an insight, caveat, or question.
Stanland et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: